Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 16894114.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors studied the association of markers of inflammation with the later development of Parkinson disease (PD) using a case-control design (196 cases and 196 matched controls). The frequency of diseases of immediate-type hypersensitivity was significantly higher in cases than controls. In addition, cases used anti-inflammatory agents less frequently than controls (nonsignificant trend). The results may support the hypothesis that there is an inflammatory component in the pathogenesis of PD.
Medical subject headings
- Inflammation
- Parkinson Disease